Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #2900
Reference
Drug alert no 8/2009
Name
Drug alert no 8 (revised): class 4
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
EFFECTIVENESS
DRUG THERAPY
PHARMACEUTICAL SERVICES
PHARMACEUTICAL INDUSTRY
Description
Attaches drug safety information from the Medicines and Healthcare Products Regulatory Agency (MHRA) for onward transmission. CP Pharmaceuticals (Wockhardt UK) report that a very low level (0.6%) of contamination with over sulphated chondroitin sulphate (OSCS) has recently been identified in the active raw material used in the manufacture of 29 batches of Multiparin and Monoparin heparin sodium injections distributed in the UK.
Contact Name
Irene Fazakerley
Contact Email
Contact Address
Pharmacy Division, Primary and Community Care Directorate, St Andrew’s House, Regent Road, Edinburgh, EH1 3DG.
Contact Phone
Created
2009-04-01 00:00:00
Click to go back to homepage